Syndax Showcases Revuforj® (revumenib) Clinical Activity in Multiple Acute Leukemia Subtypes and Settings at EHA 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. DFTX
7. GOOGL
8. MU
9. HOOD
10. MSTR

Go back to Syndax Showcases Revuforj® (revumenib) Clinical Activity in Multiple Acute Leukemia Subtypes and Settings at EHA 2026
(NASDAQ: SNDX) Delayed: 19.32 +0.32 (1.68%)
Previous Close $19.00    52 Week High $18.03 
Open $19.21    52 Week Low $8.97 
Day High $19.59    P/E N/A 
Day Low $18.94    EPS $0.00 
Volume 1,836,139